Table 2.
Participant comorbidities
| Variable | No. (%) of participants* | p value† | |
|---|---|---|---|
| Aboriginal n = 21 |
Non-Aboriginal n = 41 |
||
| No. of comorbidities, mean | 1.1 | 2.5 | 0.17 |
| Comorbidity classification | |||
| Cardiovascular | 1 (5) | 6 (15) | |
| Hypertension | 1 (5) | 10 (24) | |
| Lung disease | 1 (5) | 8 (20) | |
| Liver disease | 2 (10) | 0 | |
| Diabetes | 2 (10) | 8 (20) | |
| Cancer | 0 | 1 (2) | |
| Psychiatric disease | 3 (14) | 9 (22) | |
| Osteoarthritis | 0 | 8 (20) | |
| Kidney disease | 0 | 3 (7) | |
| Connective tissue disease | 0 | 6 (15) | |
| Alcohol misuse | 2 (10) | 2 (5) | |
| Bone fractures | 1 (5) | 5 (12) | |
| Previous spinal cord injury | 0 | 2 (5) | |
| Other | 1 (5) | 1 (2) | |
| Unknown | 9 (43) | 10 (24) | |
*
Unless indicated otherwise.
†
Calculated using Wilcoxon rank-sum test.